U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 210

1.
Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals
Elissaveta Naumova, Anastassia Mihaylova, Konstantin Stoitchkov, Milena Ivanova, Ludmila Quin, Miglena Toneva
Cancer Immunol Immunother. 2005 Feb; 54(2): 172–178. Published online 2004 Jul 10. doi: 10.1007/s00262-004-0575-z
PMCID:
PMC11032772
AbstractArticlePDF–208K
2.
Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
Beatrice M. Muriuki, Catherine S. Forconi, Erastus K. Kirwa, Titus K. Maina, Bonface O. Ariera, Jeffrey A. Bailey, Anita Ghansah, Ann M. Moormann, John M. Ong’echa
PLoS One. 2023; 18(8): e0275046. Published online 2023 Aug 30. doi: 10.1371/journal.pone.0275046
PMCID:
PMC10468049
AbstractArticlePDF–938K
3.
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells
William H. Palmer, Laura Ann Leaton, Ana Campos Codo, Bergren Crute, James Roest, Shiying Zhu, Jan Petersen, Richard P. Tobin, Patrick S. Hume, Matthew Stone, Adrie van Bokhoven, Mark E. Gerich, Martin D. McCarter, Yuwen Zhu, William J. Janssen, Julian P. Vivian, John Trowsdale, Andrew Getahun, Jamie Rossjohn, John Cambier, Liyen Loh, Paul J. Norman
Sci Immunol. Author manuscript; available in PMC 2024 Jun 30.
Published in final edited form as: Sci Immunol. 2023 Jun 30; 8(84): eade5343. Published online 2023 Jun 30. doi: 10.1126/sciimmunol.ade5343
PMCID:
PMC10360443
AbstractArticlePDF–2.9M
4.
KIR Allelic Variation and the Remission of Atopic Dermatitis Over Time
David J. Margolis, Nandita Mitra, Ole J. Hoffstad, Abha Chopra, Elizabeth J. Phillips
Immunohorizons. 2023 Jan 1; 7(1): 30–40. Published online 2023 Jan 13. doi: 10.4049/immunohorizons.2200095
PMCID:
PMC10329861
AbstractArticlePDF–845K
5.
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
Falk Heidenreich, Bose Falk, Henning Baldauf, Carolin Massalski, Gesine Schäfer, Elke Rücker-Braun, Heidi Altmann, Jürgen Sauter, Ute V. Solloch, Vinzenz Lange, Friedrich Stölzel, Christoph Röllig, Jan M. Middeke, Malte von Bonin, Christian Thiede, Kerstin Schäfer-Eckart, Carsten Müller-Tidow, Stefan W. Krause, Sabrina Kraus, Martin Kaufmann, Mathias Hänel, Hubert Serve, Andreas Neubauer, Martin Bornhäuser, Alexander H. Schmidt, Johannes Schetelig
Blood Adv. 2023 Jul 11; 7(13): 2994–3004. Published online 2023 Jan 26. doi: 10.1182/bloodadvances.2022008514
PMCID:
PMC10320196
AbstractArticlePDF–489K
6.
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
Yang Li, Chao Lv, Yang Yu, Baokang Wu, Yizhou Zhang, Qi Lang, Zhiyun Liang, Chongli Zhong, Yu Shi, Shukun Han, Feng Xu, Yu Tian
J Adv Res. 2023 May; 47: 137–150. Published online 2022 Aug 4. doi: 10.1016/j.jare.2022.07.013
PMCID:
PMC10173190
AbstractArticlePDF–1.6M
7.
Immunogenomics of killer cell Ig-like receptor (KIR) and HLA class I: Co-evolution and consequences for human health
Nicholas R. Pollock, Genelle F. Harrison, Paul J. Norman
J Allergy Clin Immunol Pract. Author manuscript; available in PMC 2023 Mar 25.
Published in final edited form as: J Allergy Clin Immunol Pract. 2022 Jul; 10(7): 1763–1775. Published online 2022 May 10. doi: 10.1016/j.jaip.2022.04.036
PMCID:
PMC10038757
AbstractArticlePDF–842K
8.
HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, Jinxiu Tian, Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi-Xin Zeng, Jincun Zhao, Lin Feng
Emerg Microbes Infect. 2023; 12(1): 2185467. Published online 2023 Mar 13. doi: 10.1080/22221751.2023.2185467
PMCID:
PMC10013568
AbstractArticlePDF–5.0M
9.
Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
David J. Margolis, Nandita Mitra, Ole J. Hoffstad, Ronald Berna, Brian S. Kim, Abha Chopra, Elizabeth J. Phillips
Sci Rep. 2023; 13: 1730. Published online 2023 Jan 31. doi: 10.1038/s41598-023-28847-y
PMCID:
PMC9889380
AbstractArticlePDF–969K
10.
Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
Gülay Sezgin, Özlem Görüroğlu Öztürk, Ayşe Özkan, Serhan Küpeli, İbrahim Bayram
Med Princ Pract. 2023 Jan; 31(6): 532–539. Published online 2022 May 10. doi: 10.1159/000524656
PMCID:
PMC9841757
AbstractArticlePDF–383K
11.
Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells
Zening Yang, Jing Li, Jiali Li, Huiwen Zheng, Heng Li, Qingrun Lai, Yanli Chen, Li Qin, Yuanyuan Zuo, Lei Guo, Haijing Shi, Longding Liu
Vaccines (Basel) 2022 Dec; 10(12): 2042. Published online 2022 Nov 29. doi: 10.3390/vaccines10122042
PMCID:
PMC9781323
AbstractArticlePDF–22M
12.
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target
Yao Wei, Xiaoxin Ren, Phillip M. Galbo, Jr, Scott Moerdler, Hao Wang, R. Alejandro Sica, Bijan Etemad-Gilbertson, Lei Shi, Liqiang Zhu, Xudong Tang, Qi Lin, Mou Peng, Fangxia Guan, Deyou Zheng, Jordan M. Chinai, Xingxing Zang
Sci Immunol. Author manuscript; available in PMC 2022 Dec 12.
Published in final edited form as: Sci Immunol. 2021 Jul 9; 6(61): eabf9792. doi: 10.1126/sciimmunol.abf9792
PMCID:
PMC9744578
AbstractArticlePDF–3.2M
13.
Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform
Dirk H Siepe, Lukas T Henneberg, Steven C Wilson, Gaelen T Hess, Michael C Bassik, Kai Zinn, K Christopher Garcia
eLife. 2022; 11: e81398. Published online 2022 Sep 30. doi: 10.7554/eLife.81398
PMCID:
PMC9578707
AbstractArticlePDF–3.3M
14.
The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection
Song Hu, Zuoyu Shao, Wei Ni, Pan Sun, Jialu Qiao, Hexing Wan, Yi Huang, Xiaolong Liu, Haoyang Zhai, Mingzhong Xiao, Binlian Sun
Front Immunol. 2022; 13: 919110. Published online 2022 Jul 7. doi: 10.3389/fimmu.2022.919110
PMCID:
PMC9301464
AbstractArticlePDF–640K
15.
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
Inès Vergnolle, Claudia Douat-Beyries, Serge Boulinguez, Jean-Baptiste Rieu, Jean-Philippe Vial, Rolande Baracou, Sylvie Boudot, Aurore Cazeneuve, Sophie Chaugne, Martine Durand, Sylvie Estival, Nicolas Lablanche, Marie-Laure Nicolau-Travers, Emilie Tournier, Laurence Lamant, François Vergez
Blood Adv. 2022 Mar 22; 6(6): 1813–1825. Published online 2022 Mar 16. doi: 10.1182/bloodadvances.2021005147
PMCID:
PMC8941477
AbstractArticlePDF–1.9M
16.
Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
Genelle F. Harrison, Laura Ann Leaton, Erica A. Harrison, Katherine M. Kichula, Marte K. Viken, Jonathan Shortt, Christopher R. Gignoux, Benedicte A. Lie, Damjan Vukcevic, Stephen Leslie, Paul J. Norman
PLoS Comput Biol. 2022 Feb; 18(2): e1009059. Published online 2022 Feb 22. doi: 10.1371/journal.pcbi.1009059
PMCID:
PMC8896733
AbstractArticlePDF–1.9M
17.
Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma
Peijia Jiang, Ilja M. Nolte, Bouke G. Hepkema, Marijke Stulp, Anke van den Berg, Arjan Diepstra
Front Immunol. 2022; 13: 829943. Published online 2022 Jan 27. doi: 10.3389/fimmu.2022.829943
PMCID:
PMC8828906
AbstractArticlePDF–1.9M
18.
KIR gene content imputation from single-nucleotide polymorphisms in the Finnish population
Jarmo Ritari, Kati Hyvärinen, Jukka Partanen, Satu Koskela
PeerJ. 2022; 10: e12692. Published online 2022 Jan 7. doi: 10.7717/peerj.12692
PMCID:
PMC8744484
AbstractArticlePDF–3.0M
19.
Increased Susceptibility of the CD57− NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response
Anastasia I. Palamarchuk, Nadezhda A. Alekseeva, Maria A. Streltsova, Maria O. Ustiuzhanina, Polina A. Kobyzeva, Sofya A. Kust, Maria V. Grechikhina, Anna A. Boyko, Olga A. Shustova, Alexander M. Sapozhnikov, Elena I. Kovalenko
Int J Mol Sci. 2021 Dec; 22(24): 13326. Published online 2021 Dec 11. doi: 10.3390/ijms222413326
PMCID:
PMC8709225
AbstractArticlePDF–3.0M
20.
Association of KIR gene polymorphisms with COVID-19 disease
Ali Hajeer, Dunia Jawdat, Salam Massadeh, Nora Aljawini, Malak S. Abedalthagafi, Yaseen M. Arabi, Manal Alaamery
Clin Immunol. 2022 Jan; 234: 108911. Published online 2021 Dec 18. doi: 10.1016/j.clim.2021.108911
PMCID:
PMC8683215
AbstractArticlePDF–444K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center